Inherited myeloproliferative neoplasm risk affects haematopoietic stem cells

Journal: Nature

Published: 2020-10-14

DOI: 10.1038/s41586-020-2786-7

Affiliations: 60

Authors: 406

Go to article
Institutions Share
Institute for Molecular Medicine Finland (FIMM), Finland 0.12
Genentech, Inc., United States of America (USA) 0.09
AbbVie Inc., United States of America (USA) 0.08
23andMe, Inc., United States of America (USA) 0.06
Merck & Co., Inc., United States of America (USA) 0.05
The Hospital District of Helsinki and Uusimaa (HUS), Finland 0.05
Pfizer Inc., United States of America (USA) 0.05
National Institute for Health and Welfare (THL), Finland 0.05
GlaxoSmithKline plc. (GSK), United Kingdom (UK) 0.04
Broad Institute of MIT and Harvard, United States of America (USA) 0.03
Northern Savo Hospital District, Finland 0.03
Pirkanmaa Hospital District, Finland 0.03
Northern Ostrobothnia Hospital District (NOHD), Finland 0.03
Sanofi, France 0.03
Celgene Corporation, United States of America (USA) 0.03
Biogen Inc., United States of America (USA) 0.03
Northern Finland Biobank Borealis, Finland 0.02
Hospital District of Southwest Finland, Finland 0.02
AstraZeneca plc, United Kingdom (UK) 0.02
Finnish Hematology Registry (FHR), Finland 0.02
Business Finland, Finland 0.01
Biobank of Eastern Finland, Finland 0.01
Central Finland Biobank, Finland 0.01
Auria Biobank, Finland 0.01
Tampere University Hospital (TAUH), Finland 0.01
Massachusetts General Hospital (MGH), United States of America (USA) 0.01
Helsinki Biobank, Finland 0
Tampere University, Finland 0
The Ohio State University (OSU), United States of America (USA) 0
University of Helsinki, Finland 0
Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), United States of America (USA) 0
NIHR Leicester Biomedical Research Centre, United Kingdom (UK) 0
Glenfield Hospital, United Kingdom (UK) 0
Lund University (LU), Sweden 0
Brigham and Women's Hospital (BWH), United States of America (USA) 0
Boston Children's Hospital (BCH), United States of America (USA) 0
Dana-Farber Cancer Institute (DFCI), United States of America (USA) 0
University Health Network (UHN), U of T, Canada 0
University of Toronto (U of T), Canada 0
Yale University, United States of America (USA) 0
Tel Aviv University (TAU), Israel 0
Central Finland Health Care District, Finland 0
Stanford University, United States of America (USA) 0
VA Boston Healthcare System, United States of America (USA) 0
Atlanta VA Medical Center, United States of America (USA) 0
Massachusetts Institute of Technology (MIT), United States of America (USA) 0
Emory University, United States of America (USA) 0
Harvard University, United States of America (USA) 0
Verve Therapeutics, Inc., United States of America (USA) 0
Harvard Stem Cell Institute (HSCI), United States of America (USA) 0
Harvard-MIT Health Sciences and Technology (HST), United States of America (USA) 0
Howard Hughes Medical Institute (HHMI), United States of America (USA) 0

Return